VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 60 filers reported holding VERA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $231,343 | -11.4% | 16,874 | +3.7% | 0.00% | -50.0% |
| Q2 2023 | $261,214 | +221.3% | 16,275 | +55.4% | 0.00% | +100.0% |
| Q1 2023 | $81,294 | -38.0% | 10,476 | +54.6% | 0.00% | 0.0% |
| Q4 2022 | $131,154 | -7.6% | 6,778 | +1.9% | 0.00% | 0.0% |
| Q3 2022 | $142,000 | +61.4% | 6,651 | +2.5% | 0.00% | 0.0% |
| Q2 2022 | $88,000 | -45.0% | 6,488 | -4.5% | 0.00% | 0.0% |
| Q1 2022 | $160,000 | +13.5% | 6,794 | +29.2% | 0.00% | 0.0% |
| Q4 2021 | $141,000 | +110.4% | 5,259 | +36.0% | 0.00% | – |
| Q3 2021 | $67,000 | – | 3,867 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,372,428 | $26,170,041 | 3.38% |
| COMMODORE CAPITAL LP | 2,824,029 | $21,914,465 | 3.34% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,002,257 | $7,747,447 | 2.16% |
| Sofinnova Investments, Inc. | 3,467,156 | $26,905,131 | 1.72% |
| Altium Capital Management LP | 286,000 | $2,219,360 | 1.23% |
| Eversept Partners, LP | 1,788,529 | $13,878,985 | 0.97% |
| SECTORAL ASSET MANAGEMENT INC | 600,300 | $4,658,328 | 0.90% |
| Octagon Capital Advisors LP | 795,000 | $6,169,200 | 0.89% |
| Carlyle Group Inc. | 2,960,231 | $22,882,586 | 0.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,300,000 | $10,088,000 | 0.22% |